REVERSE II - Multi-national validation of the men continue and HERDOO2 rule to identify low risk unprovoked venous thromboembolism patients who can discontinue anticoagulants
30 August 2016 (14:46 - 14:56)
Organised by:
About the speaker
The Ottawa Hospital, Ottawa (Canada)
11 More presentations in this session
Professor A. Goette (Paderborn, DE)
ANNEXA-4 - Andexanet alfa for reversal of Factor Xa inhibitors in patients with acute major bleeding
Doctor S. Connolly (Hamilton, CA)
Access the full session
The Event
ESC Congress 2016
30 August 2016
14:46 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Session
18 May 2025
Congress Presentation
31 August 2019
